Activities & Updates
The first HTA on COVID-19 diagnostic technology from India (FELUDA test using CRISPR technology innovation)
Posted on
22 May 2023
Views
713
The first HTA on COVID-19 diagnostic technology from India (FELUDA test using CRISPR technology innovation) was done to provide evidence on SARS-CoV-2 testing policy and highlight the role of HTA in innovations. The findings of this HTA was presented by Prof. Kanchan Mukherjee in his keynote talk at the 2021 HTAi Asia Policy Forum virtual meeting (hosted by Japan). published.
Publication on this HTA can be viewed at: https://www.sciencedirect.com/ science/article/pii/S2211883721000034